BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 34944050)

  • 1. LIM Kinases in Osteosarcoma Development.
    Brion R; Regnier L; Mullard M; Amiaud J; Rédini F; Verrecchia F
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features.
    Villalonga E; Mosrin C; Normand T; Girardin C; Serrano A; Žunar B; Doudeau M; Godin F; Bénédetti H; Vallée B
    Cells; 2023 Mar; 12(5):. PubMed ID: 36899941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LIMK2-1, a new isoform of human LIMK2, regulates actin cytoskeleton remodeling via a different signaling pathway than that of its two homologs, LIMK2a and LIMK2b.
    Vallée B; Cuberos H; Doudeau M; Godin F; Gosset D; Vourc'h P; Andres CR; Bénédetti H
    Biochem J; 2018 Dec; 475(23):3745-3761. PubMed ID: 30373762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LIMK1 and LIMK2 are important for metastatic behavior and tumor cell-induced angiogenesis of pancreatic cancer cells.
    Vlecken DH; Bagowski CP
    Zebrafish; 2009 Dec; 6(4):433-9. PubMed ID: 20047470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of LIM Kinase in the Male Urogenital System.
    Park J; Kim SW; Cho MC
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LIM kinases: cofilin and beyond.
    Prunier C; Prudent R; Kapur R; Sadoul K; Lafanechère L
    Oncotarget; 2017 Jun; 8(25):41749-41763. PubMed ID: 28445157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lim kinases, regulators of actin dynamics.
    Bernard O
    Int J Biochem Cell Biol; 2007; 39(6):1071-6. PubMed ID: 17188549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LIMK/cofilin pathway and Slingshot are implicated in human colorectal cancer progression and chemoresistance.
    Aggelou H; Chadla P; Nikou S; Karteri S; Maroulis I; Kalofonos HP; Papadaki H; Bravou V
    Virchows Arch; 2018 May; 472(5):727-737. PubMed ID: 29352327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Aspects of LIMK Regulation and Pharmacology.
    Chatterjee D; Preuss F; Dederer V; Knapp S; Mathea S
    Cells; 2022 Jan; 11(1):. PubMed ID: 35011704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of LIM kinases in central nervous system function and dysfunction.
    Cuberos H; Vallée B; Vourc'h P; Tastet J; Andres CR; Bénédetti H
    FEBS Lett; 2015 Dec; 589(24 Pt B):3795-806. PubMed ID: 26545494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
    Li ZF; Yao YD; Zhao YY; Liu Y; Liu ZH; Hu P; Zhu ZR
    J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2.
    Petrilli A; Copik A; Posadas M; Chang LS; Welling DB; Giovannini M; Fernández-Valle C
    Oncogene; 2014 Jul; 33(27):3571-82. PubMed ID: 23934191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LIM kinases are attractive targets with many macromolecular partners and only a few small molecule regulators.
    Manetti F
    Med Res Rev; 2012 Sep; 32(5):968-98. PubMed ID: 22886629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent findings confirm LIM domain kinases as emerging target candidates for cancer therapy.
    Manetti F
    Curr Cancer Drug Targets; 2012 Jun; 12(5):543-60. PubMed ID: 22414009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LIM-Kinases in Synaptic Plasticity, Memory, and Brain Diseases.
    Ben Zablah Y; Zhang H; Gugustea R; Jia Z
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho A Regulates Epidermal Growth Factor-Induced Human Osteosarcoma MG63 Cell Migration.
    Wang J; Zhang L; Qu R; Zhang L; Huang W
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29751634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrahydropyridine LIMK inhibitors: Structure activity studies and biological characterization.
    Champiré A; Berabez R; Braka A; Cosson A; Corret J; Girardin C; Serrano A; Aci-Sèche S; Bonnet P; Josselin B; Brindeau P; Ruchaud S; Leguevel R; Chatterjee D; Mathea S; Knapp S; Brion R; Verrecchia F; Vallée B; Plé K; Bénédetti H; Routier S
    Eur J Med Chem; 2024 May; 271():116391. PubMed ID: 38669909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LIM kinase and slingshot are critical for neurite extension.
    Endo M; Ohashi K; Mizuno K
    J Biol Chem; 2007 May; 282(18):13692-702. PubMed ID: 17360713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-specific proteases as therapeutic targets in paediatric primary bone tumours?
    Mullard M; Lavaud M; Regnier L; Tesfaye R; Ory B; Rédini F; Verrecchia F
    Biochem Pharmacol; 2021 Dec; 194():114797. PubMed ID: 34678225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-Hydroxythiobinupharidine Inhibits Migration of LM8 Osteosarcoma Cells by Decreasing Expression of LIM Domain Kinase 1.
    Yoshizawa M; Nakamura S; Sugiyama Y; Tamai S; Ishida Y; Sueyoshi M; Toda Y; Hosogi S; Yano Y; Ashihara E
    Anticancer Res; 2019 Dec; 39(12):6507-6513. PubMed ID: 31810915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.